Cryptosporidium parvum and Colic Adenocarcinoma
Author Information
Author(s): Gabriela Certad, Tramy Ngouanesavanh, Karine Guyot, Nausicaa Gantois, Thierry Chassat, Anthony Mouray, Laurence Fleurisse, Anthony Pinon, Jean-Charles Cailliez, Eduardo Dei-Cas, Colette Creusy
Primary Institution: Institut Pasteur de Lille, Lille, France
Hypothesis
Can Cryptosporidium parvum cause colic adenocarcinoma in immunocompromised mice?
Conclusion
C. parvum is associated with the formation of polyps and adenocarcinoma lesions in the gut of Dex-treated SCID mice.
Supporting Evidence
- C. parvum-infected mice treated with Dex developed adenocarcinoma.
- The study established a reproducible model for studying Cryptosporidium infections.
- Histopathological changes were observed in the gastrointestinal tract of infected mice.
Takeaway
This study found that a parasite called C. parvum can cause cancer in mice that are treated with a certain medication that weakens their immune system.
Methodology
Adult SCID mice were inoculated with C. parvum or C. muris and treated with Dexamethasone to study the effects on infection and cancer development.
Potential Biases
Potential bias due to the specific immunosuppression method and the use of a single animal model.
Limitations
The study was conducted in a specific animal model, which may not fully represent human disease.
Participant Demographics
Adult SCID mice, both male and female.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website